OSIC, the Open Source Imaging Consortium was created to brings together radiologists, clinicians, computational scientists, and industry leaders from around the world to transform the landscape of fibrotic and respiratory disease management. By leveraging the world’s largest and most diverse clinical and imaging databases, OSIC is working on advanced digital biomarkers designed to achieve more accurate diagnoses, clearer prognoses, and reliable predictions of therapeutic response for patients with emphysematous and fibrotic lung conditions.
Utilizing the OSIC database, Thirona has pioneered research into the automated quantification and prognosis of Idiopathic Pulmonary Fibrosis (IPF). By leveraging these diverse datasets, Thirona is advancing the understanding of longitudinal changes in IPF patients, driving the development of sophisticated tools that enhance diagnostic accuracy and track disease progression over time.
